The Discounted Cash Flow (DCF) valuation of WuXi Biologics (Cayman) Inc (2269.HK) is 14.04 HKD. With the latest stock price at 25.70 HKD, the upside of WuXi Biologics (Cayman) Inc based on DCF is -45.4%.
Based on the latest price of 25.70 HKD and our DCF valuation, WuXi Biologics (Cayman) Inc (2269.HK) is a sell. selling 2269.HK stocks now will result in a potential gain of 45.4%.
| Range | Selected | |
| WACC / Discount Rate | 7.6% - 11.2% | 9.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 9.41 - 28.74 | 14.04 |
| Upside | -63.4% - 11.8% | -45.4% |